Meta-Analysis Confirms GLP-1 Therapy Improves Outcomes in Obese Patients With HFpEF Read more about Meta-Analysis Confirms GLP-1 Therapy Improves Outcomes in Obese Patients With HFpEF
The Heart of The Matter: Unveiling the SOUL Study Results Tags GLP-1 agonists Read more about The Heart of The Matter: Unveiling the SOUL Study Results
A Deep Dive into Trial Design & Patient Profiles Tags GLP-1 agonists Read more about A Deep Dive into Trial Design & Patient Profiles
Higher-Dose Semaglutide (7.2 mg) Yields Drives Greater Weight and Glycemic Benefits in T2D Read more about Higher-Dose Semaglutide (7.2 mg) Yields Drives Greater Weight and Glycemic Benefits in T2D
Transforming Cardio Metabolic Outcomes with GLP-1 Medicines Tags GLP-1 agonists Read more about Transforming Cardio Metabolic Outcomes with GLP-1 Medicines
CSP Demonstrates Comparable One-Year Outcomes to BiVP in CRT Patients Read more about CSP Demonstrates Comparable One-Year Outcomes to BiVP in CRT Patients
Aficamten Shows Superior Structural and Functional Benefits Over Metoprolol in Obstructive HCM Tags Hypertrophic Cardiomyopathy Read more about Aficamten Shows Superior Structural and Functional Benefits Over Metoprolol in Obstructive HCM
Modernising Diabetes Care Tags Continuous glucose monitoring (CGM) Read more about Modernising Diabetes Care
Updates on Diabetic Kidney Disease Tags Diabetic Nephropathy Read more about Updates on Diabetic Kidney Disease